ERBB2 and cancer: Binding of a ligand of the epidermal growth factor (EGF) family to HER receptors induces receptor dimerization, preferentially with HER2, phosphorylation of HER2, followed by intracellular signals essential for proliferation and survival of HER2 positive cancer cells.